Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03000244 · ClinicalTrials.gov registry record

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

A clinical trial of Hematopoietic Stem Cell Transplantation and Tissue Donors, sponsored by National Cancer Institute (NCI).

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT03000244: Recruiting study of Hematopoietic Stem Cell Transplantation and Tissue Donors, sponsored by National Cancer Institute (NCI).

NCT03000244 is a study of Hematopoietic Stem Cell Transplantation and Tissue Donors that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 2,000 participants, below the 9,713-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03000244, a study of Hematopoietic Stem Cell Transplantation and Tissue Donors, is actively recruiting participants, sponsored by National Cancer Institute (NCI).

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

Background: People who have had an allogeneic hematopoietic stem cell transplant (HCT) have bone marrow or an immune system that is damaged. They get stem cells from a donor who is a relative. Researchers want to study stem cell donors and recipients to learn about the long-term effects of HCT. They want to learn how the stem cells change and how to improve their ability to fight cancer. Objective: To provide long-term follow-up care for people who underwent or will undergo HCT. To collect data, blood, and tissue samples to learn about late complications after HCT. Eligibility: Adults age 18 and older who will undergo HCT or underwent HCT and are surviving one year or more from the date of HCT. The stem cell donors for these recipients are also needed. Design: Recipients will have 1 visit each year. They will have a physical exam. They will answer questions about their medical history and health. They will receive screening and surveillance testing. They will complete brief questionnaires. Recipients will have blood tests. They may have tissue biopsies or specimens (such as tissue in their cheek or skin or bone marrow biopsy). Recipients will give their current address and phone number, and the same data for one or two other people, who can get in contact with them. After the first visit at the clinic, some recipients may see a doctor close to home to get the necessary information and send it to NIH. Donors will come to the clinic for 1 visit. They will answer questions about their medical history. Blood samples will be taken.

Primary Outcome

Survival

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2017-04-26
Est. Completion 2050-08-12
National Cancer Institute (NCI)

3,257 total trials

What NCT03000244 shows while recruiting

NCT03000244 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 9,713-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (79% lower).

The record links to 2 conditions, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 0 interventions.

NCT03000244 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03000244 about?

NCT03000244 is a clinical study titled "Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation". Background: People who have had an allogeneic hematopoietic stem cell transplant (HCT) have bone marrow or an immune system that is damaged. They get stem cells from a donor who is a relative. Researchers want to study stem cell donors and recipients to learn about the long-term effects of HCT. The...

What is the current status of trial NCT03000244?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2017-04-26. Estimated completion is 2050-08-12.

What conditions does trial NCT03000244 study?

This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation, Tissue Donors.

Who is sponsoring clinical trial NCT03000244?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03000244 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic Stem Cell Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03000244's enrollment target sits among peer trials

2,000 2nd of 26 the highest of 26 other Hematopoietic Stem Cell Transplantation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03000244, the US trial registry maintained by the National Library of Medicine. NCT03000244 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.